These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9053844

  • 1. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta.
    Jiang H, Lin JJ, Tao J, Fisher PB.
    Oncogene; 1997 Jan 30; 14(4):473-80. PubMed ID: 9053844
    [Abstract] [Full Text] [Related]

  • 2. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
    Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB.
    Oncogene; 1995 May 04; 10(9):1855-64. PubMed ID: 7753561
    [Abstract] [Full Text] [Related]

  • 3. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB.
    Oncogene; 2001 Oct 25; 20(48):7051-63. PubMed ID: 11704829
    [Abstract] [Full Text] [Related]

  • 4. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression.
    Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB.
    Oncogene; 1995 Dec 21; 11(12):2477-86. PubMed ID: 8545104
    [Abstract] [Full Text] [Related]

  • 5. Regulation of mda-7 gene expression during human melanoma differentiation.
    Madireddi MT, Dent P, Fisher PB.
    Oncogene; 2000 Mar 02; 19(10):1362-8. PubMed ID: 10713678
    [Abstract] [Full Text] [Related]

  • 6. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB, Hermo H, Solowey WE, Dietrich MC, Edwalds GM, Weinstein IB, Langer JA, Pestka S, Giacomini P, Kusama M.
    Anticancer Res; 1986 Mar 02; 6(4):765-74. PubMed ID: 2944474
    [Abstract] [Full Text] [Related]

  • 7. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
    Matin SF, Rackley RR, Sadhukhan PC, Kim MS, Novick AC, Bandyopadhyay SK.
    Cancer Res; 2001 Mar 01; 61(5):2261-6. PubMed ID: 11280796
    [Abstract] [Full Text] [Related]

  • 8. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
    Coradini D, Biffi A, Pirronello E, Di Fronzo G.
    Anticancer Res; 1994 Mar 01; 14(5A):1779-84. PubMed ID: 7531412
    [Abstract] [Full Text] [Related]

  • 9. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M.
    J Natl Cancer Inst; 2004 Nov 03; 96(21):1593-603. PubMed ID: 15523088
    [Abstract] [Full Text] [Related]

  • 10. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation.
    Madireddi MT, Dent P, Fisher PB.
    J Cell Physiol; 2000 Oct 03; 185(1):36-46. PubMed ID: 10942517
    [Abstract] [Full Text] [Related]

  • 11. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
    Vita JR, Edwalds GM, Gorey T, Housepian EM, Fetell MR, Guarini L, Langer JA, Fisher PB.
    Anticancer Res; 1988 Oct 03; 8(3):297-302. PubMed ID: 2839097
    [Abstract] [Full Text] [Related]

  • 12. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
    Schiller JH, Groveman DS, Schmid SM, Willson JK, Cummings KB, Borden EC.
    Cancer Res; 1986 Feb 03; 46(2):483-8. PubMed ID: 2416427
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
    Yuan W, Yufit T, Li L, Mori Y, Chen SJ, Varga J.
    J Cell Physiol; 1999 Apr 03; 179(1):97-108. PubMed ID: 10082137
    [Abstract] [Full Text] [Related]

  • 16. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ, Borden EC, Kalvakolanu DV.
    Clin Cancer Res; 1997 Jun 03; 3(6):931-7. PubMed ID: 9815768
    [Abstract] [Full Text] [Related]

  • 17. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G, van Koetsveld PM, de Herder WW, van der Wansem K, Janssen JA, Colao A, Lombardi G, Lamberts SW, Hofland LJ.
    Am J Physiol Endocrinol Metab; 2009 Mar 03; 296(3):E559-66. PubMed ID: 19141687
    [Abstract] [Full Text] [Related]

  • 18. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells.
    Kang JX, Liu J, Wang J, He C, Li FP.
    Carcinogenesis; 2005 Nov 03; 26(11):1934-9. PubMed ID: 15958519
    [Abstract] [Full Text] [Related]

  • 19. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL, Herrera RE, Yee D.
    Cell Growth Differ; 2000 Jun 03; 11(6):335-42. PubMed ID: 10910100
    [Abstract] [Full Text] [Related]

  • 20. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B, Nagano H, Wada H, Kondo M, Ota H, Nakamura M, Noda T, Natsag J, Yamamoto H, Doki Y, Umeshita K, Dono K, Nakamori S, Sakon M, Monden M.
    Int J Oncol; 2007 Jan 03; 30(1):201-8. PubMed ID: 17143530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.